Development of Assays to Estimate HIV Incidence: Meeting Proceedings

[Guest guest]

Dear FORUM,

Fifty leading HIV prevention experts met in Chapel Hill, North Carolina (May

13-14, 2009) to advance the development of HIV-incidence assays-tests that are

used to identify the number of new HIV cases in a population within a given time

period.

Scientists and other experts proposed various ways to make better use of current

assays and to facilitate development of new HIV incidence assays, and the best

ways to determine the global demand for these assays. The meeting was convened

by Family Health International (FHI), with support from the Bill & Melinda Gates

Foundation, the World Health Organization (WHO), the HIV Prevention Trials

Network (HPTN) and the Center for HIV/AIDS Vaccine Immunology (CHAVI). A full

report of the meeting proceedings is available at:

http://www.fhi.org/en/HIVAIDS/pub/meeting_reports/HIV_inc_assays.htm

Hock

E-MAIL: <dhock@...>

[Guest guest]

Dear ,Thank you for sending the report of the meeting in a timely manner. The only area of question is on the issue of submitting quarterly work plans before the highlighted updates are worked on and the signing of MOUs between the implementing CSOs and Ministry of Health is completed. The two items above give shape and direction for each stakeholder. With arrangement, it is clear that updates on the partnership informs the whole implementation process because it involved issues such as district distribution and the corresponding funding. Thank you.Rev. Evatt MugaruraExecutive Director,Africa Youth Leadership Development and Health(AYLDH) Initiative+256 772 322103From: dhock@...Date: Wed, 9 Sep 2009 15:45:06 -0400Subject: Development of Assays to Estimate HIV Incidence: Meeting Proceedings

Fifty leading HIV prevention experts met in Chapel Hill, North Carolina (May 13-14, 2009) to advance the development of HIV-incidence assays—tests that are used to identify the number of new HIV cases in a population within a given time period. Scientists

and other experts proposed various ways to make better use of current assays and to facilitate development of new HIV incidence assays, and the best ways to determine the global demand for these assays. The meeting was convened by Family Health International

(FHI), with support from the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the HIV Prevention Trials Network (HPTN) and the Center for HIV/AIDS Vaccine Immunology (CHAVI). A full report of the meeting proceedings is available at:

http://www.fhi.org/en/HIVAIDS/pub/meeting_reports/HIV_inc_assays.htm

Windows Live: Keep your friends up to date with what you do online. Find out more.

[Guest guest]

Dear ,Thank you for sending the report of the meeting in a timely manner. The only area of question is on the issue of submitting quarterly work plans before the highlighted updates are worked on and the signing of MOUs between the implementing CSOs and Ministry of Health is completed. The two items above give shape and direction for each stakeholder. With arrangement, it is clear that updates on the partnership informs the whole implementation process because it involved issues such as district distribution and the corresponding funding. Thank you.Rev. Evatt MugaruraExecutive Director,Africa Youth Leadership Development and Health(AYLDH) Initiative+256 772 322103From: dhock@...Date: Wed, 9 Sep 2009 15:45:06 -0400Subject: Development of Assays to Estimate HIV Incidence: Meeting Proceedings

Fifty leading HIV prevention experts met in Chapel Hill, North Carolina (May 13-14, 2009) to advance the development of HIV-incidence assays—tests that are used to identify the number of new HIV cases in a population within a given time period. Scientists

and other experts proposed various ways to make better use of current assays and to facilitate development of new HIV incidence assays, and the best ways to determine the global demand for these assays. The meeting was convened by Family Health International

(FHI), with support from the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the HIV Prevention Trials Network (HPTN) and the Center for HIV/AIDS Vaccine Immunology (CHAVI). A full report of the meeting proceedings is available at:

http://www.fhi.org/en/HIVAIDS/pub/meeting_reports/HIV_inc_assays.htm

Windows Live: Keep your friends up to date with what you do online. Find out more.